Refractory Fulminant Colitis Requiring Surgical Intervention in a Patient With Ulcerative Colitis on Atezolizumab Therapy for Small Cell Lung Cancer: An Atypical Case

Atezolizumab is a programmed death-ligand 1 (PD-L1) targeted antibody that prevents the binding of PD-L1 to specific T-cell receptors, thereby increasing anticancer immunity. It has been regarded as a useful first-line treatment in patients with small-cell lung cancer with a more tolerable side effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Steiger, Stephanie, Marcucci, Vincent, Desai, Vidisha, Zheng, Min, Parker, Glenn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Gastroenterology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239293/
https://www.ncbi.nlm.nih.gov/pubmed/35774647
http://dx.doi.org/10.7759/cureus.25437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239293/
https://www.ncbi.nlm.nih.gov/pubmed/35774647
http://dx.doi.org/10.7759/cureus.25437

Ejemplares similares